Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:FBTNASDAQ:SOPHCVE:SXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFBTFirst Trust NYSE Arca Biotechnology Index Fund$161.88+0.4%$158.26$141.38▼$183.60$1.04B0.6425,701 shs12,548 shsSOPHSOPHiA GENETICS$2.91-3.0%$2.99$2.58▼$5.63$194.06M1.0354,245 shs26,121 shsSXS3798 (SXS.V)C$0.00C$0.00▼C$0.00N/AN/AN/AN/ABeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFBTFirst Trust NYSE Arca Biotechnology Index Fund0.00%+1.00%-1.70%-6.02%+8.13%SOPHSOPHiA GENETICS0.00%+4.56%-1.65%-16.53%-40.28%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/AN/AN/AN/AN/AN/ASOPHSOPHiA GENETICS2.8453 of 5 stars3.45.00.00.03.60.00.6SXS3798 (SXS.V)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFBTFirst Trust NYSE Arca Biotechnology Index Fund 2.67Moderate Buy$161.88N/ASOPHSOPHiA GENETICS 2.75Moderate Buy$6.80133.68% UpsideSXS3798 (SXS.V) 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SXS, FBT, RSW, and SOPH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/6/2025SOPHSOPHiA GENETICSBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$5.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/AN/AN/AN/ASOPHSOPHiA GENETICS$67.17M2.89N/AN/AN/A∞SXS3798 (SXS.V)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/A22.23∞N/AN/AN/AN/AN/ASOPHSOPHiA GENETICS-$78.98M-$1.00N/AN/AN/A-110.71%-55.06%-38.33%8/5/2025 (Estimated)SXS3798 (SXS.V)N/AN/A0.00N/AN/AN/AN/AN/AN/ALatest SXS, FBT, RSW, and SOPH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025SOPHSOPHiA GENETICS-$0.21-$0.26-$0.05-$0.26$16.76 million$17.78 million3/4/2025Q4 2024SOPHSOPHiA GENETICS-$0.23-$0.23N/A-$0.23$17.71 million$17.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFBTFirst Trust NYSE Arca Biotechnology Index Fund$1.170.72%N/AN/AN/ASOPHSOPHiA GENETICSN/AN/AN/AN/AN/ASXS3798 (SXS.V)N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/ASOPHSOPHiA GENETICS0.123.803.59SXS3798 (SXS.V)N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFBTFirst Trust NYSE Arca Biotechnology Index FundN/ASOPHSOPHiA GENETICS31.59%SXS3798 (SXS.V)N/AInsider OwnershipCompanyInsider OwnershipFBTFirst Trust NYSE Arca Biotechnology Index FundN/ASOPHSOPHiA GENETICS4.88%SXS3798 (SXS.V)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFBTFirst Trust NYSE Arca Biotechnology Index FundN/A6.40 millionN/ANot OptionableSOPHSOPHiA GENETICS52066.69 million62.19 millionNot OptionableSXS3798 (SXS.V)147,000N/AN/ANot OptionableSXS, FBT, RSW, and SOPH HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSXS, FBT, RSW, and SOPH Company DescriptionsFirst Trust NYSE Arca Biotechnology Index Fund NYSEARCA:FBT$161.88 +0.60 (+0.37%) As of 04:10 PM EasternThe First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.SOPHiA GENETICS NASDAQ:SOPH$2.91 -0.09 (-3.00%) Closing price 04:00 PM EasternExtended Trading$2.84 -0.07 (-2.41%) As of 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.3798 (SXS.V) CVE:SXSSolimar Energy Limited (Solimar) is an Australia-based oil and gas production and exploration company. The Company has a multi-project asset base focused in the oil prolific San Joaquin Basin, onshore California. The Company's assets are mainly in oil prone trends adjacent giant fields and target both conventional (sandstone) and unconventional (fractured oil shale) reservoirs. Solimar is engaged in conversion of an oil and gas resource potential within its acreage to reserves. The Company operates most of its assets, holding high equity positions. This includes a control position in the Kreyenhagen oil field with significant volumes of oil intersected by numerous wells within the Company's control acreage. The Company's projects include Kreyenhagen, Bayswater, Jacalitos, SELH, Paloma and Tejon Footwall. The Company's subsidiaries include Solimar Australia Energy Pty Ltd and Livingstone Energy Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
